Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Pfizer

2 Healthcare Stocks to Watch as JPMorgan Boosts Gilead Rating

JPMorgan's upgrade on Gilead sparks bullish sentiment for the healthcare sector—here's why stocks like Pfizer and Hims & Hers are promising opportunities.

Tariff treatment: Six diagnoses for EU pharma sector amid US trade war

Tariff treatment: Six diagnoses for EU pharma sector amid US trade war

Potential US tariffs on pharmaceuticals could set off a ripple effect that extends far beyond the immediate price hikes, as both the US and Europe heavily rely on each other.

Pfizer offloads final shares in Sensodyne maker Haleon

Pfizer offloads final shares in Sensodyne maker Haleon

Haleon was formed in 2019 by the merger of the consumer healthcare businesses of British pharmaceutical group GSK and US rival Pfizer.

Evening Standard

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Are COVID-19 Vaccines Safe and Effective?

Five years after Donald Trump declared a national COVID-19 emergency, here's what the research says.

Treatment for Parkinson’s disease and restless leg syndrome is linked with risky behaviour – here’s what you need to know

Getting a headache and feeling sick are common side-effects for many medicines. Indulging in risky sexual behaviour or pathological gambling – not so common.

The Conversation

How Is Pfizer's Stock Performance Compared to Other Pharmaceuticals Stocks?

Pfizer has underperformed the pharmaceuticals industry over the past year, but analysts are moderately optimistic about the stock’s prospects.

3 Gene Therapy Stocks With Game-Changing Potential

Gene therapy stocks are transforming healthcare with revolutionary treatments. Therefore, as this sector continues to evolve, investing in gene therapy stocks like Pfizer (PFE), Sanofi (SNY), and Novartis AG (NVS) could be beneficial. Read on….

inkl

Read news from The Economist, FT, and more,
with one subscription

Pfizer Exec Booed During White House Appearance as Trump Calls Pharma Head 'Great Businessman'

Pfizer Exec Booed During White House Appearance as Trump Calls Pharma Head 'Great Businessman'

President Donald Trump's introduction of a Pfizer executive at the White House Wednesday was met with a roar of boos from the crowd.

Pfizer CEO Booed At White House Event

Pfizer CEO Booed At White House Event

President Trump's praise of Pfizer CEO at Black History Month event sparks mixed audience reactions due to company's Covid-19 vaccine controversy.

Is This Dividend Stock a Buy After Better-Than-Expected Q4 Results?

Is This Dividend Stock a Buy After Better-Than-Expected Q4 Results?

Upcoming clinical trial results will give investors a much better look into Pfizer’s operational health.

Joe Montana On Brock Purdy's Future, Notre Dame, and 49ers' Window

Football legend Joe Montana joins SI's Claudette Montana, on behalf of Pfizer, to discuss Brock Purdy's future in San Francisco, Marcus Freeman and Notre Dame,

Sports Illustrated

Factcheck: Has Pfizer released the list of side effects caused due to COVID vaccines?

Factcheck: Has Pfizer released the list of side effects caused due to COVID vaccines?

A post is doing rounds on social media claiming that vaccine maker Pfizer's COVID vaccines have side effects including few fatal ones. The posts have shared a report with the logo of the US House of Representatives with a link that is directed to the official website.

The Times of India

Pfizer's Super Bowl 2025 Ad Featuring Young Cancer Survivor Sparks Mixed Reactions

Pfizer's Super Bowl 2025 Ad Featuring Young Cancer Survivor Sparks Mixed Reactions

Pfizer's Super Bowl ad received mixed reactions on social media, but many criticized the pharma giant for saying it will "knock out" cancer amid concerns over its COVID-19 vaccine.

International Business Times

The faulty forecasts of pharma firm investors: Misguided cynics miss the promising prognosis for drugmakers Pfizer and Merck

The faulty forecasts of pharma firm investors: Misguided cynics miss the promising prognosis for drugmakers Pfizer and Merck

Pfizer and Merck, ostensibly beleaguered drugmakers, have seen their shares battered despite reporting strong earnings.

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Robert F. Kennedy had dinner with Pfizer CEO as he prepares to become health secretary, report says

Pfizer CEO certain that Trump’s administration ‘will be very, very prudent with everything they try to do’

Stock Index Futures Muted Ahead of U.S. JOLTs Report and Fed Speak, Alphabet Earnings on Tap

March S&P 500 E-Mini futures (ESH25) are down -0.01%, and March Nasdaq 100 E-Mini futures (NQH25) are up +0.08% this morning as investors awaited the latest reading on U.S. job openings, comments from Federal Reserve officials, and corporate earnings reports from heavyweight names.

Stock Index Futures Slip on Trade War Concerns, U.S. JOLTs Report and Alphabet Earnings on Tap

March S&P 500 E-Mini futures (ESH25) are down -0.21%, and March Nasdaq 100 E-Mini futures (NQH25) are down -0.11% this morning as investors adopted a cautious stance after China retaliated to new U.S. tariffs.

Option Volatility And Earnings Report For February 3 - 7

Last week was extremely busy on the earnings front, so this week is a little more sedate. That being said, we still have some big names due to report including Amazon, Alphabet, Walt Disney, Palantir Technologies, Advanced Micro Devices, Microstrategy, Uber Technologies and Pfizer.

Get all your
news in one place.

100's of premium titles.
One news app.

Major players in the anti-DEI movement: Here's who's pressuring Goldman Sachs, Pfizer, IBM, and other Fortune 500 companies to drop their policies

A guide to the people and activist organizations who paved the way for Donald Trump's attacks on diversity practices in corporate America.

The Guardian - UK

What has the UK Covid inquiry learned so far about vaccines and treatments?

In fourth part of the inquiry, questons were asked about vaccine trials, procurement and the UK’s preparedness for future pandemics

Pfizer Stock Outlook: Is Wall Street Bullish or Bearish?

Despite Pfizer trailing behind the broader market over the past year, Wall Street analysts remain moderately bullish about the stock's potential.

The Guardian - US

RFK Jr’s shifting vaccines stance worries experts ahead of confirmation hearing

Anti-vaccine rhetoric has been a lucrative enterprise for RFK Jr – one he is now trying to distance himself from

Pfizer To Pay Million In Kickback Scheme Settlement

Pfizer settles million over kickbacks for Nurtec ODT prescriptions; whistleblower rewarded.

The Conversation

People on Ozempic may have fewer heart attacks, strokes and addictions – but more nausea, vomiting and stomach pain

Ozempic and Wegovy are increasingly available in Australia and worldwide to treat type 2 diabetes and obesity.

Qorvo Stock Pops After Starboard Takes a Stake in the Apple Supplier: What to Know

Qorvo stock is soaring Friday after activist investor Starboard Value disclosed a new stake in the Apple supplier. Here's what investors need to know.

1 … 10 11 12 13

People

176,340 stories

Robert F. Kennedy Jr

Micheál Martin

Austan Goolsbee

Claudette Montana

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

US Federal Reserve

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Corporate Earnings

Places

355,269 stories

134,845 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play